AAAAAA

   
Results: 1-22 |
Results: 22
ABSENCE OF MEASLES-VIRUS (MV) GENOME IN TISSUE AND PERIPHERAL-BLOOD LYMPHOCYTES FROM PATIENTS WITH CROHNS-DISEASE (CD)
Authors: ARMITAGE E AFZAL M MINOR P GHOSH S FERGUSON A
Citation: E. Armitage et al., ABSENCE OF MEASLES-VIRUS (MV) GENOME IN TISSUE AND PERIPHERAL-BLOOD LYMPHOCYTES FROM PATIENTS WITH CROHNS-DISEASE (CD), Gut, 42, 1998, pp. 175-175
ABSENCE OF MEASLES-VIRUS (MV) GENOME IN TISSUE AND PERIPHERAL-BLOOD LYMPHOCYTES FROM PATIENTS WITH CROHNS-DISEASE (CD)
Authors: ARMITAGE E AFZAL M MINOR P GHOSH S FERGUSON A
Citation: E. Armitage et al., ABSENCE OF MEASLES-VIRUS (MV) GENOME IN TISSUE AND PERIPHERAL-BLOOD LYMPHOCYTES FROM PATIENTS WITH CROHNS-DISEASE (CD), Gastroenterology, 114(4), 1998, pp. 3783-3783
ASSESSING THE SIGNIFICANCE OF REVERSE-TRANSCRIPTASE ACTIVITY IN CHICKCELL-DERIVED VACCINES
Authors: ROBERTSON JS NICOLSON C RILEY AM BENTLEY M DUNN G CORCORAN T SCHILD GC MINOR P
Citation: Js. Robertson et al., ASSESSING THE SIGNIFICANCE OF REVERSE-TRANSCRIPTASE ACTIVITY IN CHICKCELL-DERIVED VACCINES, Biologicals, 25(4), 1997, pp. 403-414
SPECIAL TOPIC - LABORATORY CONTROL OF LIVE VIRAL VACCINES - EDITORS NOTE
Authors: MINOR P
Citation: P. Minor, SPECIAL TOPIC - LABORATORY CONTROL OF LIVE VIRAL VACCINES - EDITORS NOTE, Biologicals, 25(1), 1997, pp. 1-1
BEHAVIORAL RISK FACTOR SURVEILLANCE OF AGED MEDICARE BENEFICIARIES, 1995 (VOL 18, PG 105, 1997)
Authors: ARDAY DR ARDAY SL BOLEN J RHODES L CHIN J MINOR P
Citation: Dr. Arday et al., BEHAVIORAL RISK FACTOR SURVEILLANCE OF AGED MEDICARE BENEFICIARIES, 1995 (VOL 18, PG 105, 1997), Health care financing review, 19(1), 1997, pp. 4-4
BEHAVIORAL RISK FACTOR SURVEILLANCE OF AGED MEDICARE BENEFICIARIES, 1995
Authors: ARDAY DR ARDAY SL BOLEN J RHODES L CHIN J MINOR P
Citation: Dr. Arday et al., BEHAVIORAL RISK FACTOR SURVEILLANCE OF AGED MEDICARE BENEFICIARIES, 1995, Health care financing review, 18(4), 1997, pp. 105-123
MEDICINAL AND OTHER PRODUCTS AND HUMAN AND ANIMAL TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES - MEMORANDUM FROM A WHO MEETING
Authors: AGUZZI A BARBARA J BROWN P BUDKA H DIRINGER H DORMONT D FLANAGAN P HEESCHEN W HOPE J HORNLIMANN B KENNEY K MASTERS C MACNAUGHTON MR POCCHIARI M ROHWER RG SAFAR J SOMOGYI A TATEISHI J TAYLOR D VANDUIJN CM WILESMITH JW WILL R WISHER M ASHER D CUESTA JD FEEK C HASEBE K HORAUD F LOWER J MINOR P NANDAPALAN P PAVLOV A PEREZ AC RICKETTS M VICARI G VANAKEN WG BEAL R MENACHEARONSON D BRADLEY R BAILEY A CHALUMEAU HP GARLAND A BROOKS W SCHRIEBER R SPRENGERS E ANDJAPARIDZE AG BOLIS CL EMMANUEL JC GRIFFITHS E HEYMANN DL KABOYO W MESLIN FX MIYAGAWA S MARROQUIN AP SCHUDEL A ZEIDLER M
Citation: A. Aguzzi et al., MEDICINAL AND OTHER PRODUCTS AND HUMAN AND ANIMAL TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES - MEMORANDUM FROM A WHO MEETING, Bulletin of the World Health Organization, 75(6), 1997, pp. 505-513
COLLABORATIVE STUDY TO ASSESS THE SUITABILITY OF A PROPOSED WORKING REAGENT FOR HUMAN PARVOVIRUS B19 DNA DETECTION IN PLASMA POOLS BY GENE AMPLIFICATION TECHNIQUES
Authors: SALDANHA J MINOR P CASSINOTTI P COHEN B BEARD S COUROUCE A DAVIDSON F CLELAND A ERDMAN D GARSON J GRONER A HAMMERLE T HOROWITZ B MATSUNAGA Y MAURER W BECK G NUBLING M CHUDY M PISANI G SAVAGE M
Citation: J. Saldanha et al., COLLABORATIVE STUDY TO ASSESS THE SUITABILITY OF A PROPOSED WORKING REAGENT FOR HUMAN PARVOVIRUS B19 DNA DETECTION IN PLASMA POOLS BY GENE AMPLIFICATION TECHNIQUES, Vox sanguinis, 73(4), 1997, pp. 207-211
PRESENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 SUBTYPE A INFECTION IN A NEW-YORK COMMUNITY WITH HIGH HIV PREVALENCE - A SENTINEL SITE FOR MONITORING HIV GENETIC DIVERSITY IN NORTH-AMERICA
Authors: IRWIN KL PAU CP LUPO D PIENAZEK D LUO CC OLIVO N RAYFIELD M HU DJ WEBER JT RESPESS RA JANSSEN R MINOR P ERNST J
Citation: Kl. Irwin et al., PRESENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 SUBTYPE A INFECTION IN A NEW-YORK COMMUNITY WITH HIGH HIV PREVALENCE - A SENTINEL SITE FOR MONITORING HIV GENETIC DIVERSITY IN NORTH-AMERICA, The Journal of infectious diseases, 176(6), 1997, pp. 1629-1633
REVERSE-TRANSCRIPTASE ACTIVITY IN VACCINES DERIVED FROM CHICK-CELLS
Authors: ROBERTSON JS MINOR P
Citation: Js. Robertson et P. Minor, REVERSE-TRANSCRIPTASE ACTIVITY IN VACCINES DERIVED FROM CHICK-CELLS, Biologicals, 24(3), 1996, pp. 289-290
INCIDENCE OF HEPATITIS-C VIRUS-RNA IN ANTI-HCV-NEGATIVE PLASMA POOLS AND BLOOD PRODUCTS
Authors: SALDANHA J MINOR P
Citation: J. Saldanha et P. Minor, INCIDENCE OF HEPATITIS-C VIRUS-RNA IN ANTI-HCV-NEGATIVE PLASMA POOLS AND BLOOD PRODUCTS, Vox sanguinis, 70(4), 1996, pp. 232-234
COLLABORATIVE STUDY TO ASSESS THE SUITABILITY OF AN HCV RNA REFERENCESAMPLE FOR DETECTION OF AN HCV RNA IN PLASMA POOLS BY PCR
Authors: SALDANHA J MINOR P
Citation: J. Saldanha et P. Minor, COLLABORATIVE STUDY TO ASSESS THE SUITABILITY OF AN HCV RNA REFERENCESAMPLE FOR DETECTION OF AN HCV RNA IN PLASMA POOLS BY PCR, Vox sanguinis, 70(3), 1996, pp. 148-151
DETECTION OF HUMAN PARVOVIRUS B19 DNA IN PLASMA POOLS AND BLOOD PRODUCTS DERIVED FROM THESE POOLS - IMPLICATIONS FOR EFFICIENCY AND CONSISTENCY OF REMOVAL OF B19 DNA DURING MANUFACTURE
Authors: SALDANHA J MINOR P
Citation: J. Saldanha et P. Minor, DETECTION OF HUMAN PARVOVIRUS B19 DNA IN PLASMA POOLS AND BLOOD PRODUCTS DERIVED FROM THESE POOLS - IMPLICATIONS FOR EFFICIENCY AND CONSISTENCY OF REMOVAL OF B19 DNA DURING MANUFACTURE, British Journal of Haematology, 93(3), 1996, pp. 714-719
PERFORMANCE-CHARACTERISTICS OF A RAPID HIV ANTIBODY-ASSAY IN A HOSPITAL WITH A HIGH PREVALENCE OF HIV-INFECTION
Authors: IRWIN K OLIVO N SCHABLE CA WEBER JT JANSSEN R ERNST J BEKOETABIRI S BENJAMIN F CARNICIU S CHAVARIA C CHIRIBOGA V DISLA M FERNANDEZ A GANEA C MARTINEZ G PARSONS R ROSARIO F ROTHMAN W SANTOS W SHULMAN R VASQUEZ Y BROWN K COWART F DAUGHARTY A EDELINE M LEWIS E MCRAE B RAIMONDI V WELLS L WINTER R MINOR P
Citation: K. Irwin et al., PERFORMANCE-CHARACTERISTICS OF A RAPID HIV ANTIBODY-ASSAY IN A HOSPITAL WITH A HIGH PREVALENCE OF HIV-INFECTION, Annals of internal medicine, 125(6), 1996, pp. 471-475
THE CUTTER INCIDENT
Authors: MINOR P
Citation: P. Minor, THE CUTTER INCIDENT, Reviews in medical virology, 5(3), 1995, pp. 125-125
INTERNATIONAL ASSOCIATION OF BIOLOGICAL STANDARDIZATION - TASK-FORCE ON VACCINES
Authors: BROWN F CORBEL M FURMINGER I GRIFFITHS E HORAUD F KURTH R MINOR P VANREGENMORTEL M
Citation: F. Brown et al., INTERNATIONAL ASSOCIATION OF BIOLOGICAL STANDARDIZATION - TASK-FORCE ON VACCINES, Biologicals, 22(3), 1994, pp. 203-204
A SENSITIVE PCR METHOD FOR DETECTING HCV RNA IN PLASMA POOLS, BLOOD PRODUCTS, AND SINGLE DONATIONS
Authors: SALDANHA J MINOR P
Citation: J. Saldanha et P. Minor, A SENSITIVE PCR METHOD FOR DETECTING HCV RNA IN PLASMA POOLS, BLOOD PRODUCTS, AND SINGLE DONATIONS, Journal of medical virology, 43(1), 1994, pp. 72-76
THE PATHOGENETIC ASPECTS OF MEASLES-VIRUS INFECTION - MEMORANDUM FROMA WHO MEETING
Authors: BILLETER MA BELLINI W VANBINNENDIJK RS BORROW P BROWN F CUTTS F FENNELLY G GELLIN BG GRIFFIN D KATZ SL KOLAKOFSKY D KRETH HW LIEBERT UG LEOPARDI R MCINTOSH K TERMEULEN V MINOR P MOYER SA MURPHY BR NANICHE D NORRBY E OGRA PL OSTERHAUS ADME PAOLETTI E RIMA BK SCHNEIDERSCHAULIES S STEPHENSON JR WILD TF CROWLEY J GLUCK R VANDERHEYDEN RWJ HOMANN H LEROY O MAKINO S NAKAYAMA T MEEGAN JM RABOURDINCOMBE C ROTA P ROUX L CLEMENTS CJ LAMBERT PH PERVIKOV Y SCOTT R
Citation: Ma. Billeter et al., THE PATHOGENETIC ASPECTS OF MEASLES-VIRUS INFECTION - MEMORANDUM FROMA WHO MEETING, Bulletin of the World Health Organization, 72(2), 1994, pp. 199-206
A BELLAGIO CONSENSUS
Authors: ADA G ALBRECHT P BEALE J BELLINI WJ BLOOM B CHOPPIN PW CHU CM CLEMENTS CJ CUTTS F DEQUADROS C GELLIN BG GRIFFIN DE HALSTEAD SB HENDERSON DA HILL T JOHN TJ KATZ SL KUNOSAKAI H LAMBERT PH LUCAS A MARKOWITZ LE MARTINEZ LJ MEEGAN J MIMS C MINOR P NATHANSON N NORRBY E OLDSTONE MBA OSTERHAUS ADME PERVIKOV Y RUSSELL PK SCOTT RM SHEPARD D TERMEULEN V
Citation: G. Ada et al., A BELLAGIO CONSENSUS, The Journal of infectious diseases, 170, 1994, pp. 190000063-190000066
A BELLAGIO CONSENSUS
Authors: ADA G ALBRECHT P BEALE J BELLINI WJ BLOOM B CHOPPIN PW CHU CM CLEMENTS CJ CUTTS F DEQUADROS C GELLIN BG GRIFFIN DE HALSTEAD SB HENDERSON DA HILL T JOHN TJ KATZ SL KUNOSAKAI H LAMBERT PH LUCAS A MARKOWITZ LE MARTINEZ LJ MEEGAN J MIMS C MINOR P NATHANSON N NORRBY E OLDSTONE MBA OSTERHAUS ADME PERVIKOV Y RUSSELL PK SCOTT RM SHEPARD D TERMEULEN V
Citation: G. Ada et al., A BELLAGIO CONSENSUS, The Journal of infectious diseases, 170, 1994, pp. 190000063-190000066
CANCER-RESEARCH CAMPAIGN OPERATION MANUAL FOR CONTROL RECOMMENDATIONSFOR PRODUCTS DERIVED FROM RECOMBINANT-DNA TECHNOLOGY PREPARED FOR INVESTIGATIONAL ADMINISTRATION TO PATIENTS WITH CANCER IN PHASE-I TRIALS
Authors: BEGENT RHJ CHESTER KA CONNORS T CROWTHER D FOX B GRIFFITHS E HINCE TA LEDERMANN JA MCVIE JG MINOR P SECHER DS SCHWARTSMANN G THORPE R WILBIN C ZWIERZINA H
Citation: Rhj. Begent et al., CANCER-RESEARCH CAMPAIGN OPERATION MANUAL FOR CONTROL RECOMMENDATIONSFOR PRODUCTS DERIVED FROM RECOMBINANT-DNA TECHNOLOGY PREPARED FOR INVESTIGATIONAL ADMINISTRATION TO PATIENTS WITH CANCER IN PHASE-I TRIALS, European journal of cancer, 29A(13), 1993, pp. 1907-1910
SHEDDING OF VIRULENT POLIOVIRUS REVERTANTS DURING IMMUNIZATION WITH ORAL POLIOVIRUS VACCINE AFTER PRIOR IMMUNIZATION WITH INACTIVATED POLIOVACCINE
Authors: ABRAHAM R MINOR P DUNN G MODLIN JF OGRA PL
Citation: R. Abraham et al., SHEDDING OF VIRULENT POLIOVIRUS REVERTANTS DURING IMMUNIZATION WITH ORAL POLIOVIRUS VACCINE AFTER PRIOR IMMUNIZATION WITH INACTIVATED POLIOVACCINE, The Journal of infectious diseases, 168(5), 1993, pp. 1105-1109
Risultati: 1-22 |